Scientists hunt for hidden biomarkers in brain diseases

NCT ID NCT07235111

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to find new biological markers for neurodegenerative diseases like Alzheimer's, Parkinson's, and ALS. Researchers will analyze genetic, protein, and metabolic data from 1,200 patients to improve diagnosis, predict disease course, and monitor treatment response. The study does not test a new treatment but focuses on understanding the underlying biology.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease amyotrophic lateral sclerosis cognitive disorder frontotemporal dementia Parkinson disease semantic dementia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • Ospedale Policlinico San Martino

    RECRUITING

    Genoa, Genoa, 16132, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••